Stock listing

Biomark Diagnostics, Inc.

Selected listing: A12EKB · LS · EUR · DE

Biomark Diagnostics, Inc. (Lang & Schwarz: A12EKB), Health Services. Latest release Sep 21, 2026: BioMark Announces Participation in upcoming MSACL 2026…

A12EKB:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A12EKB
Asset type: Stock
Sector: Health Services
Industry: Medical/Nursing Services
Exchange: Lang & Schwarz
Currency: EUR

About Biomark Diagnostics, Inc.

Biomark Diagnostics, Inc. (Ticker: BUX) is a public company based in Canada, specializing in innovative diagnostic solutions. The company aims to improve patient outcomes by providing accurate and timely diagnostic information.

Latest news from Biomark Diagnostics, Inc.

BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences

September 21, 2026

BioMark's Metabolomics Platform Captures Global Scientific Interest Following Publications Demonstrating Superior Diagnostic Performance and Cost Efficiency for Liquid Biopsy

August 25, 2026

BioMark Diagnostics Endorses Global Call for Equitable Access to Early Screening on 2026 World Lung Cancer Day

July 31, 2026

BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test

June 23, 2026

BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum

April 14, 2026

All Biomark Diagnostics, Inc. news →

Research Biomark Diagnostics, Inc.

Biomark Diagnostics, Inc. company profile

View the public company page for Biomark Diagnostics, Inc. on 6ix.

Biomark Diagnostics, Inc. news

Read company news and market updates connected to Biomark Diagnostics, Inc..

Biomark Diagnostics, Inc. investor events

Find investor webinars, events, and replay context for Biomark Diagnostics, Inc..